다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Amylyx Pharmaceuticals Inc (AMLX)
Amylyx Pharmaceuticals Inc (AMLX) 뉴스

AMLX

Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AMLX

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	08:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/05/09	20:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/05/09	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/05/09	20:00	Business Wire	Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/05/08	22:00	Business Wire	Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/05/02	22:00	Business Wire	Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/04/10	22:00	Business Wire	Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/04/09	18:45	PR Newswire (US)	The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLX	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/04/08	22:00	Business Wire	Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/04/05	18:45	PR Newswire (US)	Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AMLX	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/04/04	20:00	Business Wire	Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/04/02	18:45	PR Newswire (US)	The Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/29	18:45	PR Newswire (US)	The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc.(AMLX) Shareholders	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/26	18:45	PR Newswire (US)	Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 9, 2024 to Discuss Your Rights - AMLX	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/25	21:00	PR Newswire (US)	INVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) INVESTORS WITH LOSSES OF MORE THAN $100,000 ENCOURAGED TO SEEK APPOINTMENT AS LEAD PLAINTIFF - April 9, 2024 DEADLINE	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/22	18:45	PR Newswire (US)	The Gross Law Firm Notifies Shareholders of Amylyx Pharmaceuticals, Inc.(AMLX) of a Class Action Lawsuit and an Upcoming Deadline	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/19	18:45	PR Newswire (US)	Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 9, 2024 to Discuss Your Rights - AMLX	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/14	22:00	Business Wire	Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP, FACP, to its Board of Directors	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/14	18:50	PR Newswire (US)	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 9, 2024 in Amylyx Lawsuit - AMLX	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/11	21:44	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/11	18:50	PR Newswire (US)	Amylyx Pharmaceuticals, Inc. Class Action: The Gross Law Firm Reminds Amylyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/08	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/08	21:00	Business Wire	Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/08	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/08	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/08	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/03/07	19:45	PR Newswire (US)	Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AMLX	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/02/29	08:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/02/29	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc
2024/02/29	08:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMLX	Amylyx Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:AMLX

1 2 3 4 5 6 7 8 다음 >>

Vontobel Financial Produ...

Essilor Luxottica (PK)

Vontobel Financial Produ...

BNP Paribas Issuance

OC1F27 - Janeiro 2027

Phoenix Media Investment (PK)

American Electric Power

WiBX Utility Token

Exchange Traded Fund Csi...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관